Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Alicja Urbaniak

Concepts (109)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
10
2023
1300
2.050
 Why?
Pyrans
5
2021
27
1.960
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
2022
105
1.960
 Why?
Antineoplastic Agents, Phytogenic
3
2021
87
1.440
 Why?
Colchicine
5
2021
35
1.430
 Why?
Pharmacogenetics
1
2023
55
0.930
 Why?
Polyporaceae
1
2023
3
0.920
 Why?
Mitosis
4
2022
106
0.880
 Why?
Cell Line, Tumor
10
2023
1550
0.860
 Why?
Induced Pluripotent Stem Cells
1
2022
44
0.840
 Why?
Breast Neoplasms
3
2021
1248
0.820
 Why?
Cell Proliferation
9
2023
1096
0.790
 Why?
Glioblastoma
1
2022
99
0.770
 Why?
Esters
2
2018
25
0.760
 Why?
Antibiotics, Antineoplastic
1
2021
85
0.760
 Why?
Paclitaxel
1
2020
103
0.740
 Why?
Neoplastic Stem Cells
1
2021
103
0.740
 Why?
Carbamates
1
2020
21
0.730
 Why?
Melanoma
1
2023
313
0.730
 Why?
Antioxidants
2
2019
297
0.700
 Why?
Drug Screening Assays, Antitumor
7
2021
142
0.690
 Why?
Carcinoma, Ductal, Breast
1
2020
96
0.680
 Why?
Lythraceae
1
2018
2
0.670
 Why?
Brain Neoplasms
1
2022
284
0.670
 Why?
MCF-7 Cells
4
2021
79
0.620
 Why?
Plant Extracts
1
2020
193
0.620
 Why?
Iron
1
2018
158
0.590
 Why?
Stilbenes
1
2017
65
0.580
 Why?
Exercise
1
2018
552
0.470
 Why?
Apoptosis
5
2023
1300
0.460
 Why?
Cell Survival
6
2021
657
0.440
 Why?
Drug Discovery
2
2023
90
0.410
 Why?
Vincristine
2
2022
98
0.400
 Why?
Amides
3
2020
43
0.380
 Why?
Monensin
2
2022
14
0.380
 Why?
Humans
19
2023
54284
0.370
 Why?
Cell Death
2
2020
223
0.320
 Why?
Molecular Docking Simulation
4
2021
83
0.320
 Why?
Athletes
2
2019
116
0.320
 Why?
Tubulin Modulators
4
2020
40
0.300
 Why?
Double-Blind Method
2
2019
742
0.290
 Why?
Gonadotrophs
1
2023
22
0.230
 Why?
Tamoxifen
1
2023
60
0.230
 Why?
Mycelium
1
2023
3
0.230
 Why?
Trametes
1
2023
5
0.230
 Why?
Structure-Activity Relationship
3
2021
423
0.220
 Why?
Microtubules
2
2022
57
0.220
 Why?
Dose-Response Relationship, Drug
4
2021
1476
0.220
 Why?
Organoids
1
2022
41
0.210
 Why?
Benzoxazines
1
2021
18
0.210
 Why?
Sarcoma, Ewing
1
2021
22
0.200
 Why?
Morpholines
1
2021
64
0.200
 Why?
Receptor, Cannabinoid, CB2
1
2021
60
0.200
 Why?
Tumor Microenvironment
1
2022
209
0.190
 Why?
Tissue Culture Techniques
1
2020
46
0.190
 Why?
Naphthalenes
1
2021
126
0.190
 Why?
Colchicum
1
2020
5
0.190
 Why?
Cell Division
1
2021
330
0.190
 Why?
Molecular Structure
2
2021
319
0.190
 Why?
Receptor, Cannabinoid, CB1
1
2021
128
0.190
 Why?
Cell Movement
1
2021
271
0.180
 Why?
Inhibitory Concentration 50
1
2020
80
0.180
 Why?
Cannabinoids
1
2021
108
0.180
 Why?
Receptors, Estrogen
1
2020
131
0.180
 Why?
G1 Phase
1
2018
19
0.170
 Why?
Urethane
1
2018
8
0.170
 Why?
Ergometry
1
2018
5
0.170
 Why?
Fruit
1
2019
143
0.160
 Why?
Poly(ADP-ribose) Polymerases
1
2018
43
0.160
 Why?
DNA Fragmentation
1
2018
67
0.160
 Why?
Aniline Compounds
1
2018
48
0.160
 Why?
G1 Phase Cell Cycle Checkpoints
1
2017
21
0.150
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2018
158
0.150
 Why?
Neoplasms
4
2020
1316
0.150
 Why?
Sulfonamides
1
2018
146
0.150
 Why?
Interleukin-6
1
2018
315
0.150
 Why?
Randomized Controlled Trials as Topic
1
2019
596
0.140
 Why?
Female
4
2021
28441
0.140
 Why?
Tumor Suppressor Protein p53
1
2018
250
0.140
 Why?
Dietary Supplements
1
2019
449
0.130
 Why?
Drug Design
3
2020
133
0.120
 Why?
Time Factors
1
2020
3213
0.120
 Why?
Muscle, Skeletal
1
2019
847
0.110
 Why?
Halogenation
2
2020
8
0.090
 Why?
Tubulin
2
2019
28
0.090
 Why?
Cell Cycle
2
2022
275
0.090
 Why?
Young Adult
1
2018
4318
0.080
 Why?
Cells, Cultured
2
2021
1737
0.070
 Why?
Adult
1
2022
14207
0.070
 Why?
Middle Aged
1
2020
13088
0.060
 Why?
Follicle Stimulating Hormone
1
2023
26
0.060
 Why?
bcl-2-Associated X Protein
1
2022
73
0.050
 Why?
Caspase 3
1
2022
135
0.050
 Why?
Cytotoxins
1
2021
17
0.050
 Why?
Binding, Competitive
1
2021
113
0.050
 Why?
Enzyme Activation
1
2022
329
0.050
 Why?
Carrier Proteins
1
2023
359
0.050
 Why?
Protein Biosynthesis
1
2023
273
0.050
 Why?
Ligands
1
2021
230
0.050
 Why?
Mice
2
2023
6413
0.050
 Why?
Mice, Inbred BALB C
1
2021
368
0.050
 Why?
Molecular Conformation
1
2019
73
0.050
 Why?
RNA, Messenger
1
2023
1202
0.040
 Why?
HeLa Cells
1
2018
291
0.040
 Why?
Male
1
2018
27334
0.040
 Why?
Tumor Cells, Cultured
1
2018
477
0.040
 Why?
Models, Molecular
1
2018
423
0.040
 Why?
Animals
2
2023
14385
0.030
 Why?
Aged
1
2018
10054
0.020
 Why?
Urbaniak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (109) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department